Quintiles

Information Library

To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.

The Contribution of Early-phase Clinical Data to a Drug’s Integrated Cardiac Safety Portfolio

Hear from the Experts — December 6, 2011
This article examines the financial and time benefits to incorporating intensive ECG and QT/QTc monitoring in early-phase clinical studies.
Acute Coronary Syndrome - Tailored Solutions

Case Study — February 1, 2011
Find out how our experience in multi-national cardiovascular clinical trials helped this customer reach database lock 66 days after LPO.
Commercial – Identify, Promote and Prove Treatment Value

Brochure — April 1, 2010
Quintiles has built an unmatched suite of commercial competencies that biopharma companies are leveraging for faster market access and sustained success.
New FDA Guidance on Antidiabetic Therapies

White Paper — December 11, 2009
Understanding the FDA Guidance on Assessing Cardiovascular Risks for new Antidiabetic Therapies. Learn what FDA cardiac safety requirements may mean for your development program.

Page 1 of 1 (4 results)